📰 Cancer Evolution News
Cancer Evolution News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cancer Evolution. Real-time updates on events, politics, business and more.
April 2, 2024
The Mark Foundation for Cancer Research, a leading nonprofit dedicated to advancing research that transforms the prevention, diagnosis, and treatment of cancer, proudly announces the appointment of new members to its Scientific Advisory and Industry Advisory Committees.
January 11, 2024
Charles Swanton, FRCP, BSc, PhD, has a craving to understand cancer’s evolution, and his list of achievements can prove it.
December 23, 2023
Artificial intelligence can track metastatic cancer symptoms and predict drug resistance, which encourages doctors to begin effective Extinction therapy.
December 4, 2023
The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
October 10, 2023
Predictions can shed light on more precise treatments for patients to help improve the survival rate, according to team led by Hong Kong University of Science and Technology.
May 22, 2023
For the 11th consecutive year, OncLive is honored to recognize oncology leaders whose innovations have contributed to immeasurable improvements in outcomes for countless patients.
April 13, 2023
– Highlights the use of Invitaes personalized cancer monitoring technology to correlate clinical outcomes with minimal residual disease presence – – The analysis demonstrates... | April 13, 2023
November 22, 2022
Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that United States (US) patent 11,504,398 has been granted. The patent covers the treatment of patients with an immunotherapy targeting clonal ...
November 22, 2022
- US patent is for an immunotherapy targeting clonal neoantigens identified by the Achilles Clonality Engine (ACE), including vaccine, antibody, and autologous T cell therapy approaches -LONDON, Nov. 22
July 21, 2022
– The Francis Crick Institute and The Royal Marsden team up with AI startup Owkin to understand the relationship between evolutionary and histological features in kidney cancer –– Cases of renal cell carcinoma (RCC) have more than doubled in the UK since the late 1970s – Owkin is partner...